| Callie Elizabeth Audet, OTR/L | |
|
2100 38th St Nw, Canton, OH 44709-2312 | |
| (330) 827-1551 | |
| Not Available |
| Full Name | Callie Elizabeth Audet |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 2100 38th St Nw, Canton, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003168881 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OC012549 (Pennsylvania) | Secondary |
| 225X00000X | Occupational Therapist | OT.008197 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Callie Elizabeth Audet, OTR/L 2100 38th St Nw, Canton, OH 44709-2312 Ph: (330) 827-1551 | Callie Elizabeth Audet, OTR/L 2100 38th St Nw, Canton, OH 44709-2312 Ph: (330) 827-1551 |
News Archive
Corvidia Therapeutics, a biotechnology company focused on the development of precision cardiovascular therapies, announced today that it has raised $26 million in a Series A financing, co-led by seed-investor Sofinnova Partners, and Apple Tree Partners.
Gerresheimer AG, one of the leading worldwide suppliers to the pharma and healthcare industry, remained on its growth path during the second quarter of the financial year 2010. "Our business developed very well in the second quarter. The demand for our products in the pharma industry has grown and there has also been an improvement recently in the Cosmetics and Life Science Research businesses," says Uwe Rohrhoff, the new CEO of Gerresheimer AG since June 22, 2010.
Maas Biolab researchers CSO Eskil Elmer, M.D., Ph.D. and neuroscientist Magnus Hansson, M.D., Ph.D., and colleagues have for the first time ever demonstrated the mitochondrial permeability transition (mPT) or "megapore" occurs in viable adult human neuron mitochondria and the ability of cyclosporin-A to block its formation.
A new, less toxic way to treat malignant melanoma (skin cancer) is being developed by medicinal chemists at Reading University. They have produced a range of prodrugs: compounds that offer the potential to be converted to toxic molecules only within the vicinity of tumours. These prodrugs aim to reduce the toxicity of treatment.
A unique initiative launched today by muscular dystrophy charity Duchenne UK is set to radically simplify the way necessary evidence is generated for submissions made to health technology appraisals bodies such as the National Institute for Health and Care Excellence and the Haute Autorité de Santé.
› Verified 1 days ago
Trisha Marie Altier, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2714 13th St Nw, Canton, OH 44708 Phone: 330-456-2842 Fax: 330-456-5343 | |
Pamela Thompson, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2100 38th St Nw, Canton, OH 44709 Phone: 330-492-8136 | |
Marisa Hammond, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3927 38th St Nw, Canton, OH 44718 Phone: 330-493-0096 | |
Mrs. Jane Ann Erlitz, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1320 Mercy Dr Nw, Canton, OH 44708 Phone: 330-489-1490 Fax: 330-430-6972 | |
Mrs. Wanda Kay Yarnell, MAOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1223 Market Ave N, Canton, OH 44714 Phone: 330-452-3458 Fax: 330-452-3435 | |
Anton Zopel X, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2100 38th St. Nw, Stark County Esc, Canton, OH 44709 Phone: 330-492-8136 |